Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, Jan 1997, 76-79, Vol 41, No. 1
MB Klein, CM Nelson and JL Goodman
Human granulocytic ehrlichiosis (HGE) is a rapidly emerging tick-borne
infection which presents as an acute febrile illness and is associated with
hematologic abnormalities, elevated hepatic transaminase levels, and
characteristic intracellular organisms in peripheral blood granulocytes.
Although HGE has been successfully treated with tetracyclines, its
susceptibility to other antibiotics remains unknown. No clear treatment
alternative exist for young children, pregnant women, or allergic
individuals, in whom tetracyclines are contra- indicated. We performed in
vitro antibiotic susceptibility tests with this recently isolated agent
grown in the human promyelocytic leukemia cell line HL-60. Doxycycline
(MIC, 0.25 micrograms/ml), rifampin (MIC, 0.5 micrograms/ml), rifabutin
(MIC, < or = 0.125 micrograms/ml), ciprofloxacin and ofloxacin (both
with MICs of 2 micrograms/ml), and trovafloxacin (MIC, < or = 0.125
micrograms/ml) ciprofloxacin and ofloxacin (both with MICs of 2
micrograms/ml), and trovafloxacin (MIC, < or = 0.125 micrograms/ml)
demonstrated significant activity against the HGE agent. These agents were
also bactericidal. The HGE agent was resistant to clindamycin,
trimethoprim-sulfamethoxazole, and imipenem- cilastatin, as well as to
ampicillin, ceftriaxone, erythromycin, and azithromycin, antibiotics
commonly used to treat Lyme disease. Both chloramphenicol and gentamicin
had weak inhibitory activities but were not bactericidal. Our findings
confirm the observed clinical efficacy of doxycycline and further suggest
that the rifamycins and quinolones, particularly trovafloxacin, hold
promise as alternative agents for treating this new infection.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins
Department of Medicine, University of Minnesota, Minneapolis 55455, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»